아미노글리코사이드 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "아미노글리코사이드" in Korean language version.

Last modified: 19:20:51, 9 July 2026 (UTC)

Ref.Un. Ref.Website

Global rank Korean rank

1713nih.gov

5^th place

4^th place

1512doi.org

2^nd place

3^rd place

97archive.org

6^th place

5^th place

55semanticscholar.org

15^th place

11^th place

32web.archive.org

1^st place

31merckmanuals.com

4,016^th place

1,113^th place

21merckvetmanual.com

low place

2,787^th place

11adsabs.harvard.edu

14^th place

8^th place

adsabs.harvard.edu (Global: 14^th place; Korean: 8^th place)

referenced in Bindu, LH; Reddy, PP (2008). “Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review”. 《Int J Audiol》 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). “Genetic factors in aminoglycoside toxicity”. 《Ann N Y Acad Sci》 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

archive.org (Global: 6^th place; Korean: 5^th place)

Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999). “Aminoglycosides: activity and resistance”. 《Antimicrob. Agents Chemother.》 43 (4): 727–37. doi:10.1128/AAC.43.4.727. PMC 89199. PMID 10103173.
Kroppenstedt RM, Mayilraj S, Wink JM (June 2005). “Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov. Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov”. 《Syst Appl Microbiol》 28 (4): 328–39. doi:10.1016/j.syapm.2004.12.011. PMID 15997706.
Walter P. Hammes1 and Francis C. Neuhaus (1974). “On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari”. 《Antimicrobial Agents and Chemotherapy》 6 (6): 722–728. doi:10.1128/AAC.6.6.722. PMC 444726. PMID 4451345.
Black, FO; Pesznecker, S; Stallings, V (July 2004). “Permanent gentamicin vestibuloxicity”. 《Otology and Neurotology》 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; Hannigan, IP; MacDougall, HG; Chan, RC; Halmagyi, GM (2012년 6월 18일). “Gentamicin ototoxicity: a 23-year selected case series of 103 patients”. 《Medical Journal of Australia》 196 (11): 701–4. doi:10.5694/mja11.10850. PMID 22554194.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). “Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex”. 《Acta Otolaryngologica》 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
Prayle A, Watson A, Fortnum H, Smyth A (July 2010). “Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis”. 《Thorax》 65 (7): 654–8. doi:10.1136/thx.2009.131532. PMC 2921289. PMID 20627927.

doi.org (Global: 2^nd place; Korean: 3^rd place)

dx.doi.org

Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999). “Aminoglycosides: activity and resistance”. 《Antimicrob. Agents Chemother.》 43 (4): 727–37. doi:10.1128/AAC.43.4.727. PMC 89199. PMID 10103173.
Kroppenstedt RM, Mayilraj S, Wink JM (June 2005). “Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov. Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov”. 《Syst Appl Microbiol》 28 (4): 328–39. doi:10.1016/j.syapm.2004.12.011. PMID 15997706.
Walter P. Hammes1 and Francis C. Neuhaus (1974). “On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari”. 《Antimicrobial Agents and Chemotherapy》 6 (6): 722–728. doi:10.1128/AAC.6.6.722. PMC 444726. PMID 4451345.
Pai VB, Nahata MC (October 2001). “Efficacy and safety of aerosolized tobramycin in cystic fibrosis”. 《Pediatr. Pulmonol.》 32 (4): 314–27. doi:10.1002/ppul.1125. PMID 11568993. S2CID 30108514.
Selimoglu, Erol (2007). “Aminoglycoside-induced ototoxicity”. 《Current Pharmaceutical Design》 13 (1): 119–126. doi:10.2174/138161207779313731. PMID 17266591.
L, Peterson; C, Rogers (2015년 2월 18일). “Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity”. 《South African Family Practice》 57 (2): 77–82. doi:10.1080/20786190.2014.1002220.
Black, FO; Pesznecker, S; Stallings, V (July 2004). “Permanent gentamicin vestibuloxicity”. 《Otology and Neurotology》 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; Hannigan, IP; MacDougall, HG; Chan, RC; Halmagyi, GM (2012년 6월 18일). “Gentamicin ototoxicity: a 23-year selected case series of 103 patients”. 《Medical Journal of Australia》 196 (11): 701–4. doi:10.5694/mja11.10850. PMID 22554194.
Ahmed, RM; MacDougall, HG; Halmagyi, GM (September 2011). “Unilateral vestibular loss due to systemically administered gentamicin”. 《Otology and Neurotology》 32 (7): 1158–62. doi:10.1097/MAO.0b013e31822a2107. PMID 21844784. S2CID 1412868.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). “Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex”. 《Acta Otolaryngologica》 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
Prayle A, Watson A, Fortnum H, Smyth A (July 2010). “Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis”. 《Thorax》 65 (7): 654–8. doi:10.1136/thx.2009.131532. PMC 2921289. PMID 20627927.
referenced in Bindu, LH; Reddy, PP (2008). “Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review”. 《Int J Audiol》 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). “Genetic factors in aminoglycoside toxicity”. 《Ann N Y Acad Sci》 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

merckmanuals.com (Global: 4,016^th place; Korean: 1,113^th place)

ME Levison, MD, 2012, Aminoglycosides, The Merck Manual , accessed 22 February 2014.

merckvetmanual.com (Global: low place; Korean: 2,787^th place)

DVM Boothe, DVM, PhD, 2012, Aminoglycosides (Aminocyclitols), The Merck Veterinary Manual “Aminoglycosides: Antibacterial Agents: Merck Veterinary Manual”. 2014년 3월 1일에 원본 문서에서 보존된 문서. 2014년 2월 22일에 확인함. , accessed 22 February 2014.

nih.gov (Global: 5^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999). “Aminoglycosides: activity and resistance”. 《Antimicrob. Agents Chemother.》 43 (4): 727–37. doi:10.1128/AAC.43.4.727. PMC 89199. PMID 10103173.
Kroppenstedt RM, Mayilraj S, Wink JM (June 2005). “Eight new species of the genus Micromonospora, Micromonospora citrea sp. nov., Micromonospora echinaurantiaca sp. nov., Micromonospora echinofusca sp. nov. Micromonospora fulviviridis sp. nov., Micromonospora inyonensis sp. nov., Micromonospora peucetia sp. nov., Micromonospora sagamiensis sp. nov., and Micromonospora viridifaciens sp. nov”. 《Syst Appl Microbiol》 28 (4): 328–39. doi:10.1016/j.syapm.2004.12.011. PMID 15997706.
Walter P. Hammes1 and Francis C. Neuhaus (1974). “On the Mechanism of Action of Vancomycin: Inhibition of Peptidoglycan Synthesis in Gaffkya homari”. 《Antimicrobial Agents and Chemotherapy》 6 (6): 722–728. doi:10.1128/AAC.6.6.722. PMC 444726. PMID 4451345.
Pai VB, Nahata MC (October 2001). “Efficacy and safety of aerosolized tobramycin in cystic fibrosis”. 《Pediatr. Pulmonol.》 32 (4): 314–27. doi:10.1002/ppul.1125. PMID 11568993. S2CID 30108514.
Selimoglu, Erol (2007). “Aminoglycoside-induced ototoxicity”. 《Current Pharmaceutical Design》 13 (1): 119–126. doi:10.2174/138161207779313731. PMID 17266591.
Black, FO; Pesznecker, S; Stallings, V (July 2004). “Permanent gentamicin vestibuloxicity”. 《Otology and Neurotology》 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; Hannigan, IP; MacDougall, HG; Chan, RC; Halmagyi, GM (2012년 6월 18일). “Gentamicin ototoxicity: a 23-year selected case series of 103 patients”. 《Medical Journal of Australia》 196 (11): 701–4. doi:10.5694/mja11.10850. PMID 22554194.
Ahmed, RM; MacDougall, HG; Halmagyi, GM (September 2011). “Unilateral vestibular loss due to systemically administered gentamicin”. 《Otology and Neurotology》 32 (7): 1158–62. doi:10.1097/MAO.0b013e31822a2107. PMID 21844784. S2CID 1412868.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). “Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex”. 《Acta Otolaryngologica》 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
Prayle A, Watson A, Fortnum H, Smyth A (July 2010). “Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis”. 《Thorax》 65 (7): 654–8. doi:10.1136/thx.2009.131532. PMC 2921289. PMID 20627927.
referenced in Bindu, LH; Reddy, PP (2008). “Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review”. 《Int J Audiol》 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). “Genetic factors in aminoglycoside toxicity”. 《Ann N Y Acad Sci》 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

nlm.nih.gov

의학주제표목 (MeSH)의 Aminoglycosides

pubmed.ncbi.nlm.nih.gov

Selimoglu, Erol (2007). “Aminoglycoside-induced ototoxicity”. 《Current Pharmaceutical Design》 13 (1): 119–126. doi:10.2174/138161207779313731. PMID 17266591.

semanticscholar.org (Global: 15^th place; Korean: 11^th place)

api.semanticscholar.org

Pai VB, Nahata MC (October 2001). “Efficacy and safety of aerosolized tobramycin in cystic fibrosis”. 《Pediatr. Pulmonol.》 32 (4): 314–27. doi:10.1002/ppul.1125. PMID 11568993. S2CID 30108514.
Black, FO; Pesznecker, S; Stallings, V (July 2004). “Permanent gentamicin vestibuloxicity”. 《Otology and Neurotology》 25 (4): 559–69. doi:10.1097/00129492-200407000-00025. PMID 15241236. S2CID 40285162.
Ahmed, RM; MacDougall, HG; Halmagyi, GM (September 2011). “Unilateral vestibular loss due to systemically administered gentamicin”. 《Otology and Neurotology》 32 (7): 1158–62. doi:10.1097/MAO.0b013e31822a2107. PMID 21844784. S2CID 1412868.
Ishiyama, G; Ishimaya, A; Kerber, K; Baloh, RW (October 2006). “Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex”. 《Acta Otolaryngologica》 126 (10): 1057–61. doi:10.1080/00016480600606673. PMID 16923710. S2CID 5883996.
referenced in Bindu, LH; Reddy, PP (2008). “Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review”. 《Int J Audiol》 47 (11): 702–7. doi:10.1080/14992020802215862. PMID 19031229. S2CID 25797666. See Also Fischel-Ghodsian, N (1999). “Genetic factors in aminoglycoside toxicity”. 《Ann N Y Acad Sci》 884 (1): 99–109. Bibcode:1999NYASA.884...99F. doi:10.1111/j.1749-6632.1999.tb08639.x. PMID 10842587. S2CID 10280462.

web.archive.org (Global: 1^st place; Korean: 1^st place)

The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome Martin Lovmar and Måns Ehrenberg
DVM Boothe, DVM, PhD, 2012, Aminoglycosides (Aminocyclitols), The Merck Veterinary Manual “Aminoglycosides: Antibacterial Agents: Merck Veterinary Manual”. 2014년 3월 1일에 원본 문서에서 보존된 문서. 2014년 2월 22일에 확인함. , accessed 22 February 2014.

아미노글리코사이드 (Korean Wikipedia)

adsabs.harvard.edu (Global: 14th place; Korean: 8th place)

archive.org (Global: 6th place; Korean: 5th place)

doi.org (Global: 2nd place; Korean: 3rd place)